I want to make clinical trials available to everyone, everywhere by bringing the practice of pharmacy into clinical research. Believe it or not, this has never been done before.
It will improve healthcare by giving people worldwide clear access to more lifesaving medicines and access to the medication experts — the pharmacist.
In an interview with Fotis Georgiadis for Authority Magazine, Gerald E. Finken, CEO of RxE2 shares his passion and his career journey, leading up to the newest innovation in clinical research.
Gerald is a licensed pharmacist with almost 40 years of experience in the biotechnology and pharmaceutical industries. In 1997, he founded Clinical Supplies Management, Inc. (CSM), a clinical supplies packaging and labeling company, where he invented On-Demand packaging and labeling as well as Clinical Trial Research Pharmacist (CTRP®) services. He also pioneered Direct-to-Patient services. In 2013, he founded Center Point Clinical Services and subsequently created the innovative Siteless CRO model. In 2020, Gerald launched RxE2 where he now serves as CEO. Gerald focuses on innovation, disruptive business strategies, and growth opportunities.